| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/16/2010 | US20100234444 Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| 09/16/2010 | US20100234401 6,9-Disubstituted Purine Derivatives and Their Use For Treating Skin |
| 09/16/2010 | US20100234400 Compounds that maintain pluripotency of embryonic stem cells |
| 09/16/2010 | US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators |
| 09/16/2010 | US20100234303 Agents, methods and uses |
| 09/16/2010 | US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234290 Stabilized Insulin-like Growth Factor Polypeptides |
| 09/16/2010 | US20100234243 Ptu compounds for promoting the in vitro culture of (highly pigmented) melanocytes |
| 09/16/2010 | US20100233819 Robo: a novel family of polypeptides and nucleic acids |
| 09/16/2010 | US20100233813 Plant stem cell line derived from cambium of herbaceious plant with storage root and method for isolating the same |
| 09/16/2010 | US20100233812 Membrane made of a nanostructured material |
| 09/16/2010 | US20100233811 Cell seeding module |
| 09/16/2010 | US20100233810 In vivo production of small interfering rnas that mediate gene silencing |
| 09/16/2010 | US20100233809 Cytotoxic ribonuclease variants |
| 09/16/2010 | US20100233808 Liver tissue source |
| 09/16/2010 | US20100233807 Substrate Recognition By Differentiable Human Mesenchymal Stem Cells |
| 09/16/2010 | US20100233806 Carbocyclic bicyclic nucleic acid analogs |
| 09/16/2010 | US20100233805 Method of enhancing cell growth using alkyl-amine-n-oxide (aanox) |
| 09/16/2010 | US20100233804 Generation of pluripotent stem cells using recombinant proteins |
| 09/16/2010 | US20100233803 Fusion Polypeptides Capable of Activating Receptors |
| 09/16/2010 | US20100233802 Cells useful for immuno-based botulinum toxin serotype a activity assays |
| 09/16/2010 | US20100233762 Thermostable y-family polymerases and chimeras |
| 09/16/2010 | US20100233759 Method for production of polypeptide |
| 09/16/2010 | US20100233755 Pdx1-expressing dorsal and ventral foregut endoderm |
| 09/16/2010 | US20100233750 Human Blood Brain Barrier Model |
| 09/16/2010 | US20100233730 Therapeutic modulation of autophagy |
| 09/16/2010 | US20100233726 Tandem fluorescent protein constructs |
| 09/16/2010 | US20100233706 Methods to fix and detect nucleic acids |
| 09/16/2010 | US20100233694 Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
| 09/16/2010 | US20100233674 Cells for detection and production of influenza and parainfluenza viruses |
| 09/16/2010 | US20100233669 Bioburden-reducing antibiotic composition and method of use |
| 09/16/2010 | US20100233277 Biodegradable polymer scaffold and process for preparation thereof |
| 09/16/2010 | US20100233249 Contraceptive methods and compositions related to proteasomal interference |
| 09/16/2010 | US20100233239 Templated islet cells and small islet cell clusters for diabetes treatment |
| 09/16/2010 | US20100233216 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method |
| 09/16/2010 | US20100233215 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND |
| 09/16/2010 | US20100233209 Chikungunya virus infectious clones and uses therefor |
| 09/16/2010 | US20100233200 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells |
| 09/16/2010 | US20100233197 Method for generating tolerogenic dendritic cells employing decreased temperature |
| 09/16/2010 | US20100233195 Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof |
| 09/16/2010 | US20100233192 Manufacturing Method of Activated Lymphocytes for Immunotherapy |
| 09/16/2010 | US20100233187 Gene products differentially expressed in cancerous cells |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |
| 09/16/2010 | US20100233182 Antibodies against Clostridium difficile toxins and uses thereof |
| 09/16/2010 | US20100233181 Antibodies against clostridium difficile toxins and uses thereof |
| 09/16/2010 | US20100233180 Antibodies that bind to an epitope on the huntington's disease protein |
| 09/16/2010 | US20100233177 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9) |
| 09/16/2010 | US20100233173 Multispecific epitope binding proteins and uses thereof |
| 09/16/2010 | US20100233172 Methods of inhibiting quiescent tumor proliferation |
| 09/16/2010 | US20100233170 Fully human antibodies against N-Cadherin |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233165 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 09/16/2010 | US20100233160 Monoclonal Anti-Annexin A3 Antibodies for the Detection of Prostate Carcinoma |
| 09/16/2010 | US20100233157 Human antibodies against human fas and their use |
| 09/16/2010 | US20100233154 Targeted binding agents directed to heparanase and uses thereof 463 |
| 09/16/2010 | US20100233153 Novel gene disruptions, compositions and the methods relating thereto |
| 09/16/2010 | US20100233143 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells |
| 09/16/2010 | US20100233142 Stem Cells Derived from Uniparental Embryos and Methods of Use Thereof |
| 09/16/2010 | US20100233141 Compositions And Methods For The Delivery Of Biologically Active RNAs |
| 09/16/2010 | US20100233140 Collagen-containing cell carrier |
| 09/16/2010 | US20100233139 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 09/16/2010 | US20100233137 Compositions and Methods for Modification of Target Cells and to Their Uses Thereof |
| 09/16/2010 | US20100233136 Isolated populations of cells and methods of generating and using same |
| 09/16/2010 | US20100233135 Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
| 09/16/2010 | US20100233133 Tissue repair |
| 09/16/2010 | US20100233132 Formation of vascular networks using embryonic stem cells |
| 09/16/2010 | US20100233131 Selenium dedifferentiated cell, preparation method and usage thereof |
| 09/16/2010 | US20100233130 Method and Apparatus for Maintenance and Expansion of Hematopoietic Stem Cells From Mononuclear Cells |
| 09/16/2010 | US20100233106 Small-molecule modulators of melanin expression |
| 09/16/2010 | US20100233084 Method for Delivery Across the Blood Brain Barrier |
| 09/16/2010 | US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 09/16/2010 | CA2755219A1 Antibodies binding to pivka-ii amino acids 13-27 |
| 09/16/2010 | CA2754708A1 Method for monitoring cell culture |
| 09/16/2010 | CA2754603A1 Non-integrating retroviral vector vaccines |
| 09/16/2010 | CA2754591A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 09/16/2010 | CA2754109A1 Infectious disease cellular immunotherapy |
| 09/16/2010 | CA2753282A1 Use of serine protease inhibitors in the treatment of neutropenia |
| 09/16/2010 | CA2735242A1 Cells useful for immuno-based botulinum toxin serotype a activity assays |
| 09/15/2010 | EP2228448A1 MU-1 member of the cytokine receptor family |
| 09/15/2010 | EP2228446A1 Secreted and transmembrane polypeptieds and nucleic acids encoding the same |
| 09/15/2010 | EP2228445A1 Fucose Transporter |
| 09/15/2010 | EP2228439A1 Mammalian gamete and embryo culture media supplement and method of using same |
| 09/15/2010 | EP2228438A1 Soluble poly(amido-amines) as promoters of cell adhesion, proliferation and differentiation |
| 09/15/2010 | EP2228435A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 09/15/2010 | EP2228434A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 09/15/2010 | EP2228392A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228382A1 Method for mixing object into gelled assembly |
| 09/15/2010 | EP2228070A2 Modulation of granulosa cell apoptosis |
| 09/15/2010 | EP2227549A1 Organic compounds |
| 09/15/2010 | EP2227540A2 De-differentiation of human cells |
| 09/15/2010 | EP2227487A1 Ddr1-mediated cell purification of pancreatic endocrine cells through their progenitors |
| 09/15/2010 | EP2227253A1 Vaccine comprising monocyte or immature myeloid cells(imc) which were loaded with the ligand of natural killer t cell and antigen |
| 09/15/2010 | EP1737949B1 Endothelial progenitor cells and methods of use thereof |
| 09/15/2010 | EP1623017B1 Generation and isolation of antigen-specific t cells |
| 09/15/2010 | EP1576179B1 Methods and compositions for inducing apoptosis in cancer cells |
| 09/15/2010 | EP1533381B1 Adenovirus vector |